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In the Netherlands, measles vaccination started in 1976,
with 14-month-old babies. A two-dose schedule, implemented
in 1987, offered a combined measles, mumps, and rubella
(MMR) vaccine to 14-month-old babies and 9-year-old
children. The national vaccine coverage for both doses of
MMR is 96% (1), but this rate is not uniform throughout the
country. In 1999, 34 (6%) of the 539 municipalities had
vaccine coverage of <90% for the first dose of MMR (1). These
34 municipalities, which are concentrated in a geographic belt
from the southwest to the mideast of the country, contain
clusters of orthodox reformed communities, most of whose
members refrain from vaccination on religious grounds. The
communities (estimated population 300,000, 2% of Dutch
population) form a strongly coherent social group that has its
own churches and schools and consists of large families (2).
Notification data show that measles epidemics have mainly
affected unvaccinated persons and have occurred every 5 to 7
years since the introduction of vaccination: in 1976, 1983,
1987-1988, 1992-1994, and 1999-2000 (3,4).
The most recent epidemic was first noticed on June 21,
1999. Five cases of measles were reported to a Public Health
Service (PHS) in the Netherlands by a general practitioner
(GP) from a municipality with low vaccine coverage (78% for
the first dose of MMR)(1,5). The five patients all attended the
same regional, orthodox reformed elementary school. Two
days later, the headmaster informed PHS that 80 (19%) of the
412 pupils were ill at home.
After laboratory confirmation (specific serum immuno-
globulin [Ig] M antibodies) of the first clinical cases, we
started a study with a twofold aim: 1) to evaluate alternative
methods for diagnosing measles (including detection of
specific IgM antibodies in saliva and measles virus in
oropharyngeal swabs and urine through reverse tran-
scriptase-polymerase chain reaction [RT-PCR]) and 2) (on
which this article reports) to assess the attack rates among
pupils and their families and the severity of disease
associated with measles infection.
Methods
Study Population
We sought participation of all patients whose cases were
reported to PHS between June 21 and July 2, 1999, and their
household contacts, as well as all pupils from grade 1 (n = 48,
5 and 6 years of age) of the orthodox reformed elementary
school. We requested two house calls, the first right before
summer holidays (July 2), and the second right after the
holidays (August 23). On the first visit, a questionnaire was
completed and blood, saliva, oropharyngeal swab, and urine
specimens were collected from all consenting household
members, even those without symptoms. On the second visit,
a questionnaire was completed, and blood and saliva
specimens were obtained. On the first questionnaire,
demographic variables, symptoms, and history of measles,
measles vaccination status, travel abroad, and contact with
measles were detailed. On the second visit, the section on
symptoms was completed, if applicable, and two forms with
additional questions were filled out. The first form inquired
about complications, GP consultations, hospitalization, and
medication. On the second form, limited information was
gathered on all other household members (date of birth, sex,
and recent measles infection).
Pupils from grades 2 to 8 were sent the same
questionnaires and additional questions before and after
summer vacation. We received the names of pupils in grade 0
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(preschool, which is voluntary) after vacation; therefore, we
sent them the questionnaires in August only. Measles
vaccination history of all 412 pupils of the school (grades 0
to 8) was verified at the Provincial Vaccination
Administrations (PVA).
Laboratory Tests
The presence of specific serum IgM antibodies was
determined with a commercially available IgM-capture
enzyme-linked immunosorbent assay (ELISA) according to
procedures recommended by the manufacturer (Meddens mu-
capture ELISA for measles, Biotest, Denville, NJ). IgG
antibody concentrations were measured by an in-house
ELISA (6).
Case Classification
We classified cases according to a modified Centers for
Disease Control and Prevention case definition (7): Confirmed
cases had >3 days of rash, fever >38.3°C, and either cough,
conjunctivitis, or coryza; suspected cases had rash and fever
according to questionnaire or recent measles according to
form, with limited information on household members of
pupils. We considered positive serologic results (positive IgM
or a minimal fourfold rise in IgG titer) or virus isolation from
blood or oropharyngeal swab to be laboratory evidence of
measles infection.
Data Analyses
Attack rates for clinically confirmed and suspected
measles cases were calculated by sex, year of birth,
vaccination history, history of measles, and susceptibility,
i.e., no vaccination, no history of measles, and birth in 1986 or
later. Persons born before 1987 experienced measles
epidemics in 1987-88 and in 1992-93. This was confirmed by
the fact that we observed only one clinical case (the patient
was born in 1986) among all persons born before 1987 (n =
226). Therefore, we considered all persons born before 1986
without information on history of measles to have had
measles.
Vaccine efficacy estimates were based on the attack rate
of measles among pupils who reported no history of measles in
the questionnaire and by vaccination history as given by PVA.
Symptoms and complications as reported in the question-
naires were described for those who had clinically confirmed
or suspected measles and who had completed at least one
questionnaire. We used the chi-square test to test differences
in attack rates regarding categorical variables. A p value of
<0.05 was considered statistically significant.
Results
Response
Responses to questionnaires, limited information, and
collected biological samples (from pupils and household
members) are shown in Table 1. All families with one or more
reported measles patients from June 21 through July 2, 1999,
had elementary school pupils in their households. We
obtained questionnaires on 299 persons and limited
information on 283 of their household members from 123
families, and we obtained biological samples from 100
persons in 26 families.
Description of the Outbreak
In total, 213 cases of measles (110 confirmed and 103
suspected) were identified (Table 2); 138 were in pupils. All
suspected cases were epidemiologically linked to a confirmed
case through school or family contacts. Therefore, we consider
suspected cases true measles cases and describe our results
for the confirmed and suspected cases together.
The epidemic curve is shown in Figure 1. Day 1 of rash
was known in 137 of the 213 confirmed and suspected cases
and occurred from June 15 to July 20, 1999. The number of
Table 1. Participation in measles outbreak investigation, the
Netherlands, 1999–2000
Household
  Pupils  members    Total
 (n = 412) (n = 375)a (n = 787)
Sources   n   %   n   %   n   %
Questionnaire and   50 (12)   36 (10)   86 (11)
 biological samplesb
Questionnaire 197 (48)   16 (  4) 213 (27)
Limited information     0 (  0)   14 (  4)   14 (  2)
 and biological
 samples
Limited information     8 (  2) 261 (70) 269 (34)
 (August only)
No information 157 (38)   48 (13) 205 (26)
a Number of household members not attending the elementary school of the 255
participating pupils.
bQuestionnaires for all 86 participants from whom questionnaires and
biological sample(s) were collected both in July and August.
Table 2. Measles cases by clinical and laboratory case classification, the
Netherlands, 1999–2000
 Number
Clinical providing      Positive
case biological    laboratory
classification Number  samples   confirmation
Confirmed 110 41 34a
Suspected 103 10   5a
Noncase 369 48   5b
Total 582 99c 44
aAll 12 clinically confirmed and suspected cases without laboratory
confirmation had no rash until 3-20 days after sampling.
bDetails on these 5 persons are in Table 4.
cHere, 99 persons with laboratory case classification are shown instead of 100
as in Table 1, since 1 person did not provide blood and throat swab specimens,
but only saliva and urine.
Figure 1. Distribution of clinically confirmed and suspected cases by
date of onset of rash (n = 137).Research
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persons per household was 3 to 18 (median 6). The number of
reported cases per household was 0 to 9 (median 2): 37 (30%)
households reported no cases, including 12 (10%) households
with children vaccinated against measles.
Attack Rates
The overall attack rate among confirmed and suspected
cases was 37% (Table 3), 0% for the oldest pupils to 88% for the
youngest (Figure 2). Two (1%) of the 213 patients were born in
1999; 166 (78%) from 1992 to 1998; and 43 (20%) from 1988 to
1991. Two (1%) patients were born before 1988 (1986 and
1987). The distribution of cases and attack rate by sex,
vaccination history, history of measles, and susceptibility
(i.e., no vaccination, no history of measles, and born in or after
1986), is shown in Table 3. Except for sex, all variables were
associated with the attack rate (p <0.05).
The attack rate among susceptible pupils was 91% (133 of
146). Of the 28 nonpupils considered susceptible, 24 (86%)
had clinical cases (Table 3). Three of the four who did not
become ill were probably protected by maternal antibodies
(date of birth from December 1998 to April 1999).
Among the 69 pupils considered not susceptible because
of reported history of measles, one had clinical symptoms and
laboratory confirmation of measles infection (Table 3).
According to the questionnaire, this grade 1 pupil had
measles in 1998. No vaccination was registered at PVA. This
child probably had another rash disease in 1998. No cases
were observed among the 195 nonpupils considered not
susceptible (Table 3).
Laboratory Results
The diagnosis was laboratory confirmed for 39 of the 51
clinically confirmed and suspected cases with one or two
biological samples, the first of which was collected at or just
after Day 1 of rash (IgM postive or IgG titer rise). We had
collected only one sample in each of the remaining 12 cases;
measles rash did not develop in these patients until 3 to 20
days later. As expected, IgM antibodies could not be detected
in these cases. Five of 48 asymptomatic persons who had
provided biological samples had laboratory evidence of
measles infection (Tables 2, 4).
Vaccination History and Vaccine Efficacy
Of all 412 pupils, 28 (7%) had been vaccinated, according
to PVA records. Of the 255 participating pupils, 25 (10%) had
been vaccinated: 20 had one dose of MMR vaccine, and 5 had
had two doses. None of the 25 vaccinated pupils reported
measles symptoms (Table 3). Four (one parent and three
young children) (10%) of the 42 nonpupils with a
questionnaire reported vaccination against measles. None
reported symptoms.
Symptoms and Complications
The median number of days the rash lasted was 5 (10th-
90th percentile, 3-9), the median number of days with fever
was 6 (10th-90th percentile, 3-9). Of the 148 patients with
confirmed or suspected measles who had given at least one
answer about symptoms during measles disease, 54 (37%)
reported Koplik’s spots; 93 (63%) itching; 139 (94%) coughing;
136 (92%) conjunctivitis; 116 (78%) sore throat; 101 (68%)
coryza; 86 (58%) diarrhea; 57 (39%) vomiting; 79 (53%)
headache; and 28 (19%) aching joints.
Table 3. Attack rates (ARs) for clinically confirmed and suspected measles cases among pupils and their household contacts, by sex, vaccination
history, history of measles, and susceptibility, the Netherlands, 1999–2000
               Pupils     Household members                        Total
  n Cases AR (%)   n Cases AR (%)   n  (%) Cases AR (%)
Sex
  Male 129   69 (53) 174 38 (22) 303   (52) 107 (35)
  Female 126   69 (55) 153 37 (24) 279   (48) 106 (38)
Vaccination historya
  Vaccinated   25     0 (  0)     4   0    0   29   (  5)     0 (  0)
  Unvaccinated 230 138 (62)   48 24 (50) 278   (48) 162 (58)
  Unknown     0     0    0 275 51 (18) 275   (47)   51 (19)
History of measles
  Yes   69     1 (  2) 192   0 (  0) 261   (54)     1 (  0)
  No 168 133 (79)   39 26 (67) 207   (36) 159 (77)
  Unknown   18     4 (31)   96 49 (47) 114   (20)   53 (45)
Susceptibilityb
  Yes 146 133 (91)   28 24 (86) 174   (30) 157 (90)
  No   92     1 (  1) 195   0 (  0) 287   (49)     1 (  0)
  Unknown   17     4 (31) 104 51 (49) 121   (21)   54 (45)
Total 255 138 (54) 327 75 (23) 582 (100) 213 (37)
aVaccination history for pupils according to Provincial Vaccine Administration records, for nonpupils according to questionnaire.
bSusceptibility of pupils: with no recorded measles-containing vaccination(s) and with no reported history of measles. Susceptibility of nonpupils: with no reported
measles-containing vaccination(s) and with no reported history of measles for those born in 1986 or later.
Figure 2. Attack rates by year of birth for clinically confirmed and
suspected cases (n = 213).Research
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Of the 162 patients with confirmed or suspected measles
who completed at least one questionnaire, 40 (25%) reported
one or more complications; one of the 40 was hospitalized for
delirium (Table 5). Of the 40 patients with complications, 27
(68%) consulted GPs, who prescribed medication for 22 (55%)
children. Of the 22 children, 19 were given antibiotics: 9 for
pneumonia, 9 for otitis media, and 1 for cystitis. Antipyretic
and analgesic medications were also prescribed. The
complication rate did not differ between confirmed and
suspected cases (26% vs. 24%).
Conclusion
We have described an outbreak of measles in a mostly
unvaccinated population. From this outbreak, measles
spread and affected mainly (94%) unvaccinated persons from
orthodox reformed communities. By May 2000, 3,292 cases of
measles were reported to the national registry, including
three measles-related deaths and 72 hospitalizations.
Attack Rates
The susceptibility levels and attack rates were closely
related to the number of previous epidemics encountered;
those persons born after 1992, when the last epidemic began,
had the highest susceptibility levels and attack rates. The
1999 birth cohort and part of the 1998 birth cohort are
exceptions because they were partially protected by maternal
antibodies. Sex was not associated with the attack rate, which
is in accordance with previous reports (8). The infectivity of
the measles virus is shown by the high attack rate (90%)
among those considered susceptible (i.e., those with no history
of measles or vaccination).
Import and Export of Measles Virus
Measles viruses isolated from patients showed that the
epidemic was caused by a D6 type measles virus, a genotype
widely distributed throughout Europe (9). Genotype D6 had
frequently been isolated from unrelated cases in the
Netherlands between 1993 and 1999 (van Binnendijk et al.,
unpub. data). During this period, the number of measles cases
reported in the Netherlands decreased to one of the lowest
rates in Europe (<1 per million in 1998). However, because of
low vaccine coverage in orthodox reformed communities, the
number of susceptible persons increases. Consequently,
measles epidemics still occur, despite high national vaccine
coverage and population immunity (1,6). Previously, we
showed that measles is not endemic in the Netherlands, not
even in areas with low vaccine coverage (10). This was
confirmed in this 1999-2000 epidemic; no more cases were
reported within 1 year after the start of the outbreak.
Therefore, we assume that the epidemic was initiated by
import from another country. Until the measles virus is
eradicated, circulation will continue worldwide and epidem-
ics will occur. During this epidemic, visiting relatives
exported measles to Canada. The outbreak was restricted to
17 cases within an orthodox reformed community in Canada
as a result of stringent measures (e.g., closing the school) (11).
Laboratory Results
We observed five asymptomatic persons with serologic
proof of measles infection. All had been in close contact with
one or more measles patients. Two were children, one
vaccinated (#5 in Table 4) and one without recorded measles
vaccination or history of measles disease (#4). Incomplete
immunity in the presence of residual maternal antibodies
may have developed in the latter child during the 1992
measles epidemic (12). Two adults (#2 and #3) reported
history of measles, the third (#1) reported no history of
measles but might have had measles, on the basis of the year
of birth. However, this person might also have had subclinical
primary infection.
We assume that the increase in specific IgG (#2-#5)
reflects secondary immune response in persons reexposed to
measles virus, as has been demonstrated (13-15). We have not
been able to detect virus, either by virus culture or RT-PCR
from blood or oropharyngeal swab (data not shown), from any
of these subclinically reinfected persons, as was recently
shown for an immune mother of an adult measles patient (16).
However, even if virus can be detected in blood, urine, or
saliva, the critical issue is whether the virus load in these
subclinically reinfected persons is high enough to transmit
the measles virus.
Vaccination History and Vaccine Efficacy
We observed low vaccine coverage (7% to 10%), but
excellent vaccine effectiveness (100%) for the measles
component of the MMR vaccine; none of the vaccinated
persons had measles symptoms. In the measles epidemic
following this outbreak, 5% of the reported cases patients
were vaccinated; almost all of them had received one dose (5).
Table 4. Asymptomatic persons with laboratory confirmation of measles
virus infection, the Netherlands, 1999–2000
 History
Parti- Year of      of    Measles       Laboratory
cipant   birth  measles  vaccination       confirmation
1 1974 Unknown        No IgM positive
Data on IgG titer
  rise not available
2 1980     Yes Data missing IgM negative
>fourfold IgG titer rise
3 1982     Yes Data missing IgM negative
>fourfold IgG titer rise
4 1992      No        No IgM negative
>fourfold IgG titer rise
5 1994      No       Yes IgM negative
>fourfold IgG titer rise
IgM = immunoglobulin M; IgG = immunoglobulin G.
Table 5. Self-reported complications in clinically confirmed and
suspected cases, from questionnaire data, the Netherlands, 1999–2000
Self-reported complications Number    %
Hospitalization for delirium     1     0.6
Otitis media   18   11
Pneumonia   10     6
Earache     5     3
Stomachache     3     2
Cystitis     1     0.6
Laryngitis     1     0.6
Severe coughing     1     0.6
No complications 113   70
Data missing     9     6
Total 162 100Research
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The real percentage of vaccinated patients is probably smaller.
We expect that more vaccinated than unvaccinated persons
with measles symptoms are seen and reported by GPs.
Symptoms and Complications
Measles is sometimes thought of as a mild disease.
However, we observed a self-reported complication rate of
25% for all patients, 68% of whom consulted a GP. We do not
know whether children who did not complete a form on
complications consulted a GP. The percentage of consulta-
tions for uncomplicated measles cases could be smaller than
that for complicated cases. Therefore, the percentage of
consultations for all cases may be overestimated.
The complication rate of 25% is based on self-reported
complications, and the diagnosis was not always confirmed by
a physician. This could explain why the complication rate is
somewhat higher than expected for measles (8,12). Still, burden
of disease was very high in the participating measles patients.
During the following epidemic (1999-2000), three measles-
related deaths and 72 hospitalizations were reported (5).
In this descriptive study of a measles outbreak with an
attack rate of 90% among susceptible persons, we have shown
that measles disease is severe, even in an industrialized
country. Vaccination is the most effective means of preventing
the disease and its complications. The national vaccine
coverage of 96% for both doses of MMR is theoretically high
enough to eliminate measles (17). However, despite this very
high coverage, measles epidemics still occur as a result of
areas with low vaccine coverage. In these sociodemographi-
cally clustered, mainly unvaccinated communities, the
number of susceptible people increases, and consequently
epidemics occur periodically. The clustering of unvaccinated
persons is the critical factor for measles elimination in the
Netherlands.
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